IRIS
BERNARDO, MARIA ESTER
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 3.007
NA - Nord America 1.689
EU - Europa 1.264
SA - Sud America 934
AF - Africa 62
OC - Oceania 8
Continente sconosciuto - Info sul continente non disponibili 4
Totale 6.968
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.601
SG - Singapore 1.317
CN - Cina 808
BR - Brasile 776
SE - Svezia 466
HK - Hong Kong 428
IT - Italia 249
VN - Vietnam 244
RU - Federazione Russa 133
DE - Germania 108
AR - Argentina 71
FI - Finlandia 58
GB - Regno Unito 57
NL - Olanda 49
CA - Canada 45
AT - Austria 40
IN - India 40
ID - Indonesia 33
MX - Messico 31
EC - Ecuador 28
PL - Polonia 27
BD - Bangladesh 24
ZA - Sudafrica 23
FR - Francia 22
TR - Turchia 18
IQ - Iraq 17
UA - Ucraina 15
VE - Venezuela 15
JP - Giappone 14
CO - Colombia 13
ES - Italia 11
PY - Paraguay 11
UZ - Uzbekistan 11
LT - Lituania 10
EG - Egitto 9
MA - Marocco 9
SA - Arabia Saudita 9
KE - Kenya 8
NP - Nepal 7
PE - Perù 7
AZ - Azerbaigian 6
IL - Israele 6
UY - Uruguay 6
CL - Cile 5
DO - Repubblica Dominicana 5
IE - Irlanda 5
IR - Iran 5
JO - Giordania 5
AE - Emirati Arabi Uniti 4
CR - Costa Rica 4
EU - Europa 4
AU - Australia 3
DZ - Algeria 3
NZ - Nuova Zelanda 3
PK - Pakistan 3
TN - Tunisia 3
BE - Belgio 2
ET - Etiopia 2
GR - Grecia 2
JM - Giamaica 2
PT - Portogallo 2
AM - Armenia 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BO - Bolivia 1
BW - Botswana 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
CZ - Repubblica Ceca 1
EE - Estonia 1
GA - Gabon 1
GE - Georgia 1
KW - Kuwait 1
KZ - Kazakistan 1
LB - Libano 1
MD - Moldavia 1
MK - Macedonia 1
MN - Mongolia 1
MY - Malesia 1
NG - Nigeria 1
NR - Nauru 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
SR - Suriname 1
TL - Timor Orientale 1
TT - Trinidad e Tobago 1
TV - Tuvalu 1
Totale 6.968
Salva come PNG Salva come JPEG
Città #
Singapore 471
Hong Kong 428
Dallas 337
Shanghai 233
Ashburn 182
Hefei 160
Lawrence 138
Princeton 138
Beijing 131
Moscow 103
Ho Chi Minh City 96
Milan 87
New York 84
São Paulo 63
Los Angeles 55
Hanoi 46
Helsinki 37
Boardman 33
Dronten 26
Nuremberg 25
Montreal 23
Rio de Janeiro 23
Rome 22
Warsaw 22
Munich 21
Orem 19
London 18
Santa Clara 17
Chicago 16
Chennai 15
Curitiba 15
Brooklyn 14
Guangzhou 14
Haiphong 14
Johannesburg 14
Tokyo 14
Brasília 13
Guarulhos 13
Houston 13
Poplar 13
Turku 13
Vienna 13
Cesano Boscone 12
Denver 12
Frankfurt am Main 12
Boston 11
Guayaquil 11
Porto Alegre 11
Seattle 11
Tashkent 11
Toronto 11
Belo Horizonte 10
Shenzhen 10
Stockholm 10
Brescia 9
Columbus 9
Hải Dương 9
Mexico City 9
Monza 9
Salvador 9
Atlanta 8
Council Bluffs 8
Lappeenranta 8
The Dalles 8
Ankara 7
Boydton 7
Cumming 7
Da Nang 7
Ipatinga 7
Nairobi 7
Phoenix 7
Quito 7
Recife 7
Reston 7
San Diego 7
San Francisco 7
Sorocaba 7
Fortaleza 6
Itaquaquecetuba 6
Jakarta 6
Joinville 6
Mumbai 6
Querétaro 6
Sumaré 6
Thái Bình 6
Viamão 6
Amman 5
Asunción 5
Barcelona 5
Cairo 5
Campinas 5
Caxias do Sul 5
Cuiabá 5
Florianópolis 5
Fremont 5
Goiânia 5
Itu 5
Jacareí 5
Manchester 5
Medellín 5
Totale 3.665
Salva come PNG Salva come JPEG
Nome #
Rapamycin-Based GvHD Prophylaxis Is Effective in T-Cell Replete Unmanipulated Haploidentical Peripheral Stem Cell Transplantation for Advanced Haematological Malignancies: Results in 46 Patients 192
Lentiviral haematopoietic stem-cell gene therapy for early-onset metachromatic leukodystrophy: long-term results from a non-randomised, open-label, phase 1/2 trial and expanded access 109
A Novel Assay in Whole Blood Demonstrates Restoration of Mitochondrial Activity in Phagocytes After Successful HSCT in Hyperinflamed X-Linked Chronic Granulomatous Disease 104
Autologous bone marrow-derived mesenchymal stromal cells in the treatment of fistulising Crohn's disease 94
Case Report: Consistent disease manifestations with a staggered time course in two identical twins affected by adenosine deaminase 2 deficiency 92
Hematopoietic stem-and progenitor-cell gene therapy for hurler syndrome 91
Familial platelet disorder with propensity to acute myelogenous leukemia: Genetic heterogeneity and progression to leukemia via acquisition of clonal chromosome anomalies 86
Bone marrow harvesting from paediatric patients undergoing haematopoietic stem cell gene therapy 83
Access to gene therapy for rare diseases when commercialization is not fit for purpose 80
Optimization of in vitro expansion of human multipotent mesenchymal stromal cells for cell-therapy approaches: Further insights in the search for a fatal calf serum substitute 78
Peripheral blood stem and progenitor cell collection in pediatric candidates for ex vivo gene therapy: a 10-year series 77
Wiskott–Aldrich syndrome: Oral findings and microbiota in children and review of the literature 77
An innovative platform approach for the development of ex-vivo gene therapies for the treatment of lysosomal storage diseases with skeletal involvement 75
Bone marrow stromal cells from β-thalassemia patients have impaired hematopoietic supportive capacity 74
Early skeletal outcomes after hematopoietic stem and progenitor cell gene therapy for Hurler syndrome 72
An early-senescence state in aged mesenchymal stromal cells contributes to hematopoietic stem and progenitor cell clonogenic impairment through the activation of a pro-inflammatory program 72
Pioglitazone as a novel therapeutic approach in chronic granulomatous disease 72
A GLB1 transgene with enhanced therapeutic potential for the preclinical development of ex-vivo gene therapy to treat mucopolysaccharidosis type IVB 69
Assessment of human herpesvirus-6 infection in mesenchymal stromal cells ex vivo expanded for clinical use 65
Long-term and real-world safety and efficacy of retroviral gene therapy for adenosine deaminase deficiency 64
Allogeneic hematopoietic stem cell transplantation in thalassemia major: Results of a reduced-toxicity conditioning regimen based on the use of treosulfan 63
Bone marrow-derived mesenchymal stromal cells (MSC) locally injected for refractory fistulizing Crohn’s disease modulate immunoglobulin production 62
Allogeneic hematopoietic stem cell transplantation may restore gluten tolerance in patients with celiac disease 62
Preemptive therapy of EBV-related lymphoproliferative disease after pediatric haploidentical stem cell transplantation 62
Up to 10.5 Years of Follow-Up in 17 Subjects Treated with Hematopoietic Stem and Progenitor Cell Lentiviral Gene Therapy for Wiskott-Aldrich Syndrome 61
Emapalumab treatment in an ADA-SCID patient with refractory hemophagocytic lymphohistiocytosis-related graft failure and disseminated BCGitis 61
A low thymic function is associated with leukemia relapse in children given T-cell-depleted HLA-haploidentical stem cell transplantation 61
Bone Marrow-Derived Mesenchymal Stromal Cell Intra-Fistular Injections Induce An Up-Regulation Of Foxp3+ Regulatory T-Cells In Patients With Crohn’s Disease 60
Biological and functional characterization of bone marrow-derived mesenchymal stromal cells from patients affected by primary immunodeficiency 59
Ex Vivo and In Vivo Gene Therapy for Mucopolysaccharidoses: State of the Art 59
Biological, functional and genetic characterization of bone marrow-derived mesenchymal stromal cells from pediatric patients affected by acute lymphoblastic leukemia 58
A new enzyme-linked immunosorbent assay for a total anti-T lymphocyte globulin determination: Development, analytical validation, and clinical applications 57
Anti-leukemia activity of alloreactive NK cells in KIR ligand-mismatched haploidentical HSCT for pediatric patients: Evaluation of the functional role of activating KIR and redefinition of inhibitory KIR specificity 57
The cannabinoid receptor type 2 as mediator of mesenchymal stromal cell immunosuppressive properties 57
Safety and efficacy of mesenchymal stromal cell therapy in autoimmune disorders 56
Cannabinoid receptor 2 as antiobesity target: Inflammation, fat storage, and browning modulation 56
Evidence of Treatment Benefits in Patients with Mucopolysaccharidosis Type I-Hurler in Long-term Follow-up Using a New Magnetic Resonance Imaging Scoring System 56
Mild SARS-CoV-2 Infection After Gene Therapy in a Child With Wiskott-Aldrich Syndrome: A Case Report 56
Autologous bone marrow-derived mesenchymal stem cell infusion in crohn's disease patients with fistulas 55
Mesenchymal stromal cells improve the transplantation outcome of CRISPR-Cas9 gene-edited human HSPCs. 53
Chromosome anomalies in bone marrow as primary cause of aplastic or hypoplastic conditions and peripheral cytopenia: Disorders due to secondary impairment of RUNX1 and MPL genes 53
The EHA Research Roadmap: Hematopoietic Stem Cell Gene Therapy 53
Lentiviral haemopoietic stem/progenitor cell gene therapy for treatment of Wiskott-Aldrich syndrome: interim results of a non-randomised, open-label, phase 1/2 clinical study 51
Familial myelodysplastic syndromes, monosomy 7/trisomy 8, and mutator effects 51
Haematopoietic stem cell gene therapy in inborn errors of metabolism 50
The human leucocyte antigen-G 14-basepair polymorphism correlates with graft-versus-host disease in unrelated bone marrow transplantation for thalassaemia 50
Hematopoietic Stem Cell Transplantation for Mucopolysaccharidoses: Past, Present, and Future 49
In-vivo T-regs generation by rapamycin-mycophenolate-ATG as a new platform for GvHD prophylaxis in T-cell repleted unmanipulated haploidentical peripheral stem cell transplantation: results in 59 patients 48
Intrabone hematopoietic stem cell gene therapy for adult and pediatric patients affected by transfusion-dependent ß-thalassemia 48
MSCs in Pediatric Hematopoietic Stem Cell Transplantation (Chapter 26) 48
The Role of Conditioning in Hematopoietic Stem-Cell Gene Therapy 48
Inhibition of B-cell proliferation and antibody production by mesenchymal stromal cells is mediated by T cells 48
Adult autoimmune enteropathy treated with autologous bone marrow-derived mesenchymal stromal cells 47
The outcome of children with Fanconi anemia given hematopoietic stem cell transplantation and the influence of fludarabine in the conditioning regimen: a report from the Italian pediatric group 47
Cord blood transplantation in childhood 46
How I treat relapsed childhood acute lymphoblastic leukemia 45
Resistance to neoplastic transformation of ex-vivo expanded human mesenchymal stromal cells after exposure to supramaximal physical and chemical stress 45
Long-Term Effects of Atidarsagene Autotemcel for Metachromatic Leukodystrophy 45
Ex vivo expansion of mesenchymal stromal cells 44
γδ T-cell reconstitution after HLA-haploidentical hematopoietic transplantation depleted of TCR-αβ+/CD19+ lymphocytes 44
Tailoring cells for clinical needs: Meeting report from the Advanced Therapy in Healthcare symposium (October 28-29 2017, Doha, Qatar) 43
Clofarabine, cyclophosphamide and etoposide as single-course re-induction therapy for children with refractory/multiple relapsed acute lymphoblastic leukaemia 43
Treosulfan-based conditioning regimen for allogeneic haematopoietic stem cell transplantation in patients with thalassaemia major 43
Successful Treatment With Ledipasvir/Sofosbuvir in an Infant With Severe Combined Immunodeficiency Caused by Adenosine Deaminase Deficiency With HCV Allowed Gene Therapy with Strimvelis 43
Multiparametric Whole Blood Dissection: A one-shot comprehensive picture of the human hematopoietic system 42
Cord blood transplantation in children with haematological malignancies 42
Strategies to optimize the outcome of children given T-cell depleted HLA-haploidentical hematopoietic stem cell transplantation 42
Generation of mesenchymal stromal cells in the presence of platelet lysate: A phenotypic and functional comparison of umbilical cord blood- and bone marrow-derived progenitors 42
Gene therapy for mucopolysaccharidoses: In vivo and ex vivo approaches 10 Technology 1004 Medical Biotechnology 41
Mesenchymal Stromal Cells: Role in the BM Niche and in the Support of Hematopoietic Stem Cell Transplantation 41
Co-transplantation of ex-vivo expanded mesenchymal stem cells accelerates lymphocyte recovery and may reduce the risk of graft failure in haploidentical hematopoietic stem cell transplantation 41
Transgenic expression of IL-10 by lentiviral vectors for increasing the anti-inflammatory efficacy of mesenchymal stromal cells 40
Effects Of Bone Marrow-Derived Mesenchymal Stromal Cells Infused In Fistulas Of Patients With Perianal Crohn’s Disease On Serum Cytokine Pattern, Salivary Iga Production, And Circulating Lymphocyte Subsets 40
Mesenchymal stromal cells and chronic inflammatory bowel disease 40
Mesenchymal stromal cells: a novel and effective strategy for facilitating engraftment and accelerating hematopoietic recovery after transplantation? 40
Immunomodulatory properties of MSCs (Chapter 7) 39
Mesenchymal stromal cells: A novel treatment modality for tissue repair 39
Low percentages of circulating CD8+/CD45RA+ human T lymphocytes expressing β7 integrin correlate with the occurrence of intestinal acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation 39
Donor multipotent mesenchymal stromal cells may engraft in pediatric patients given either cord blood or bone marrow transplantation 39
MPSI Manifestations and Treatment Outcome: Skeletal Focus 38
Haematopoietic stem cell transplantation for patients with Thalassemia 38
Bone Marrow-Derived Mesenchymal Stromal Cells Locally Injected Induce An Up-Regulation Of Both Circulating And Mucosal Foxp3+ Regulatory T-Cells In Patients With Perianal Crohn’s Disease 38
Bone osteoblastic and mesenchymal stromal cells lack primarily tumoral features in multiple myeloma patients 38
Hematopoietic stem cell transplantation for Wiskott-Aldrich syndrome: an EBMT Inborn Errors Working Party analysis. 38
Current and Future Perspective in Hematopoietic Stem Progenitor Cell-gene Therapy for Inborn Errors of Metabolism 37
Lentiviral gene therapy corrects platelet phenotype and function in Wiskott-Aldrich patients 37
Mesenchymal stromal cell therapy: a revolution in Regenerative Medicine? 37
Human bone marrow-derived mesenchymal stem cells do not undergo transformation after long-term in vitro culture and do not exhibit telomere maintenance mechanisms 37
Neonatal umbilical cord blood transplantation halts skeletal disease progression in the murine model of MPS-I 37
MSCs for Gastrointestinal disorders (Chapter 30) 36
Use of Defibrotide to help prevent post-transplant endothelial injury in a genetically predisposed infant with metachromatic leukodystrophy undergoing hematopoietic stem cell gene therapy 36
Mesenchymal stromal cells and hematopoietic stem cell transplantation 36
Gene therapy for lysosomal storage disorders: recent advances for metachromatic leukodystrophy and mucopolysaccaridosis I 36
Role of ex vivo Expanded Mesenchymal Stromal Cells in Determining Hematopoietic Stem Cell Transplantation Outcome 35
Use Of Autologous Bone Marrow-Derived Mesenchymal Stromal Cells In The Treatment Of Adult Autoimmune Enterophaty 35
Cell-Cycle phases and genetic profile of bone marrow-derived mesenchymal stromal cells expanded in vitro from healthy donors 35
COVID-19 - Impact on Childhood Haematology Patients 35
Single-cell cloning of human, donor-derived antileukemia T-cell lines for in vitro separation of graft-versus-leukemia effect from graft-versus-host reaction 35
ISAnalytics enables longitudinal and high-throughput clonal tracking studies in hematopoietic stem cell gene therapy applications 34
Successful treatment of fistulizing crohn's disease with local infusions of autologous bone marrow-derived mesenchymal stem cells 34
Totale 5.398
Salva come PNG Salva come JPEG
Categoria #
all - tutte 57.171
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 57.171
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20216 0 0 0 0 0 2 3 0 0 1 0 0
2021/202285 0 0 0 43 4 7 4 3 15 1 4 4
2022/2023866 313 147 47 4 31 124 13 31 97 6 36 17
2023/2024435 20 23 30 47 36 45 84 32 3 12 31 72
2024/20252.409 317 48 99 36 67 154 253 209 449 325 228 224
2025/20263.248 472 583 479 1.072 491 151 0 0 0 0 0 0
Totale 7.149